Log In
Print
BCIQ
Print
Print this Print this
 

AYX1

  Manage Alerts
Collapse Summary General Information
Company Adynxx Inc.
DescriptionSynthetic, dsDNA small molecule inhibitor of early growth response 1 (EGR1)
Molecular Target Early growth response 1 (EGR1)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationPain
Indication DetailsPrevent acute and chronic post-surgical pain; Prevent chronic pain; Prevent post-surgical pain
Regulatory Designation

U.S. - Fast Track (Prevent chronic pain)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today